课题基金 / 基金详情

Association of Androgen Receptor Polymorphisms with Damage in SLE

Association of Androgen Receptor Polymorphisms with Damage in SLE
雄激素受体多态性与 SLE 损伤的关联
批准号:
8738406
负责人:
BETTY P TSAO
金额:
$10.68万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-23 至 2015-12-01

项目摘要

项目成果

BETTY P TSAO的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):多种基因和环境因素可能影响系统性红斑狼疮(SLE)的疾病易感性和表达。虽然对致病基因的了解还远未完成,但在确定40多个易感基因或位点方面取得了重大进展。然而,对于遗传因素对SLE预后的影响知之甚少。系统性狼疮国际合作诊所开发了一种名为SLICC/ACR损伤指数的仪器,对SLE的损伤进行测量,定义为疾病活动性、治疗干预或疾病诊断后出现的合并症导致的不可逆变化。由于男性SLE患者往往在病程中较早出现损害,性别差异(包括性激素、性染色体相关基因和/或女性X染色体失活(XCI))可能在SLE的疾病进展中发挥作用。我们选择了位于X染色体上的雄激素受体基因(AR),并测试了具有较高雄激素反激活活性的较短的多聚gln多态性(d17)是否与SLE的加速损伤有关。我们对129名男性和418名女性SLE患者的初步研究结果显示:1)男性在发病的前5年损伤加速,尤其是发生肾损害的风险;2)损伤增加(SDI e2)与AR CAG重复长度较短、累积泼尼松剂量较高、病程较长有显著关联。这些数据表明,AR患者对睾酮和脱氢表雄酮(DHEA)结合的反应增强,由短CAG重复序列雄激素反激活活性增强介导,这可能是男女SLE损害的预后标志。虽然DHEA在治疗SLE表现方面有益处,但最近的研究结果不一致,需要进一步的研究。我们假设一个或多个x连锁的AR变异体易导致SLE中累积的损害,并建议建立一个多种族的数据集,包括5000名临床特征明确的SLE患者,其中包括500名男性患者,以确定1)男性SLE患者是否有整体或肾脏损害的风险,2)AR变异体有助于识别风险患者
英文摘要
DESCRIPTION (provided by applicant): Multiple genes and environmental factors likely contribute to disease susceptibility and expression in systemic lupus erythematosus (SLE). While an understanding of the genes that contribute to the pathogenesis is far from complete, significant progress has been made in identifying more than 40 susceptibility genes or loci. However, much less is known about genetic factors predisposing to good outcomes in SLE. Damage in SLE, defined by irreversible changes either as result of disease activity, therapeutic interventions or co-morbid conditions occurring after the disease diagnosis, is measured by an instrument developed by the Systemic Lupus International Collaborating Clinics as the SLICC/ACR damage index. Since male SLE patients tend to develop damage earlier in the course of the illness, it is plausible that gender differences including sex hormones, sex chromosome-linked genes and/or X chromosome inactivation (XCI) in women may play a role in disease progression in SLE. We selected the androgen receptor gene (AR) located on the X chromosome and tested whether shorter polyGLN polymorphisms (d17) conferring higher androgen transactivation activity were associated with accelerated damage in SLE. Our preliminary results of 129 men and 418 women affected with SLE showed 1) accelerated damage in men during the first 5 years of disease especially in risk for developing renal damage, and 2) significant associations of increased damage (SDI e 2) with shorter CAG repeat length of AR, higher cumulative prednisone dosage, and longer disease duration. These data suggested a heightened response to testosterone and dehydroepiandrosterone (DHEA) binding mediated by enhanced androgen transactivation activity of short CAG repeat in AR might be a prognostic marker for SLE damage in both genders. Although DHEA has previously shown beneficial in treating SLE manifestations, recent studies have yielded inconsistent results, highlighting the need for further studies. We hypothesize that one or more X-linked AR variants predispose to damage accrual in SLE, and propose to assemble a multiethnic dataset of >5,000 clinically well-characterized SLE patients containing > 500 male patients to address whether 1) men with SLE are at risk for overall or renal damage, 2) AR variants help identify at risk patients of both gender for damage accrual, and 3) differential levels of AR responsive gene expression contribute to damage in SLE. Results from these studies are likely to illuminate disease mechanisms, improve risk assessment of damage accrual, and promote consideration of selective androgen receptor modulators in therapeutic interventions of SLE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of human SLE causal variant NCF1.pR90H in promoting kidney damage
Pathogenic role of SAT1 variants in monogenic lupus
Association of Androgen Receptor Polymorphisms with Damage in SLE
Association of Androgen Receptor Polymorphisms with Damage in SLE
海外基金